Intellectual
Property
The
Human BioMolecular Research Institute (HBRI) has filed the
following patents with the United States Patent and Trademark
Office. For further information or for inquiries into licensing
intellectual property at HBRI please contact the Director,
HBRI, 5310 Eastgate Mall, San Diego, CA 92121; Telephone (858)
458-9305; Fax: (858) 458-9311 or email: JCashman@hbri.org.
Patents
Title: Synthetic compounds and derivatives as modulators of
central nervous system neurotransmitters.
Title: cDNA encoding a novel esterase: Development of a better
cocaine detoxication catalyst useful in central nervous system
and peripheral diseases.
Human BioMolecular Research Institute Technology Transfer.
HBRI
partners with for-profit and non-profit groups to help promote
research and develop products from intellectual property discovered
and developed at the Institute.
Bringing scientific discoveries to collaborators and developing
research partners in the for-profit sector is an end-product
of research done at the Institute. While the goal of HBRI
is not to develop products to sell, HBRI encourages collaborations
and partnerships with other groups that have an interest in
developing intellectual property discovered at the HBRI for
the good of society. For more information contact the scientists
involved in the discovery or contact the Director indicated
at left.
|